Treatment outcomes of long-acting injectable naltrexone versus oral naltrexone in alcohol use disorder in veterans

INTRODUCTION: In veterans, the prevalence of 12-month and lifetime alcohol use disorder (AUD) is 14.8% and 42.2%, respectively. Alcohol use disorder treatment is often plagued by medication discontinuation with relapse rates being as high as 39% in patients who sought treatment. One proposed benefit...

Descripción completa

Detalles Bibliográficos
Autores principales: Leighty, Anne E., Ansara, Elayne D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: College of Psychiatric & Neurologic Pharmacists 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881114/
https://www.ncbi.nlm.nih.gov/pubmed/31857935
http://dx.doi.org/10.9740/mhc.2019.11.392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881114/
https://www.ncbi.nlm.nih.gov/pubmed/31857935
http://dx.doi.org/10.9740/mhc.2019.11.392

Ejemplares similares